Literature DB >> 3131953

Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections.

R Colombari1, F Bonetti, G Zamboni, A Scarpa, F Marino, A Tomezzoli, P Capelli, F Menestrina, M Chilosi, L Fiore-Donati.   

Abstract

The distribution of a recently produced melanoma specific antibody (HMB-45) has been evaluated histochemically on paraffin sections in a large panel of melanocytic and non melanocytic tumours. Results have been compared with the presence of S-100 protein. HMB-45 was shown to be a highly specific antibody being present only in melanomas, junctional melanocytes and histogenetically related neoplasms such as melanocytic neuroectodermal tumour of infancy and, at low levels, on a proportion of peripheral nerve sheath tumours. The high specificity of HMB-45 antibody, coupled with the greater sensitivity of S-100, makes the combined use of these markers practical in the differential diagnosis of skin tumours and of metastatic lesions of uncertain primary site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131953     DOI: 10.1007/bf00844277

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  23 in total

1.  Common and uncommon melanocytic nevi and borderline melanomas.

Authors:  R J Reed; H Ichinose; W H Clark; M C Mihm
Journal:  Semin Oncol       Date:  1975-06       Impact factor: 4.929

2.  New sites of human S-100 immunoreactivity detected with monoclonal antibodies.

Authors:  M J Vanstapel; K C Gatter; C de Wolf-Peeters; D Y Mason; V D Desmet
Journal:  Am J Clin Pathol       Date:  1986-02       Impact factor: 2.493

Review 3.  The migration and differentiation of neural crest cells.

Authors:  J A Weston
Journal:  Adv Morphog       Date:  1970

4.  Pigmented spindle cell nevus. Clinical and histologic review of 90 cases.

Authors:  R W Sagebiel; E K Chinn; B M Egbert
Journal:  Am J Surg Pathol       Date:  1984-09       Impact factor: 6.394

Review 5.  Malignant melanotic neuroectodermal tumor of infancy: a clinical, pathologic, ultrastructural and tissue culture study.

Authors:  L P Dehner; R K Sibley; J J Sauk; R A Vickers; M E Nesbit; A S Leonard; D E Waite; J E Neeley; J Ophoven
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

6.  Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.

Authors:  K Maeda; K Jimbow
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

7.  Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.

Authors:  L Suter; E B Bröcker; J Brüggen; D J Ruiter; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

10.  Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells.

Authors:  A Godal; O Bruland; E Haug; M Aas; O Fodstad
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

View more
  10 in total

1.  Alveolar soft-part sarcoma of the uterine corpus: histological, immunocytochemical and ultrastructural study of a case.

Authors:  L Guillou; E Lamoureux; S Masse; J Costa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Primary amelanotic malignant melanoma of the oesophagus--a case report.

Authors:  B M Loftus; P Broe; O Johnston; M Leader
Journal:  Ir J Med Sci       Date:  1994-03       Impact factor: 1.568

3.  Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Authors:  Francesca Avogadri; Sacha Gnjatic; Jodie Tassello; Denise Frosina; Nicole Hanson; Megan Laudenbach; Erika Ritter; Taha Merghoub; Klaus J Busam; Achim A Jungbluth
Journal:  Am J Dermatopathol       Date:  2016-03       Impact factor: 1.533

4.  Metastases of malignant melanoma simulating soft tissue sarcoma. A clinico-pathological, light- and electron microscopic and immunohistochemical study of 21 cases.

Authors:  P Lodding; L G Kindblom; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.

Authors:  N Hatta; M Takata; K Takehara; K Ohara
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

6.  Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45.

Authors:  C Zimmer; J Gottschalk; S Goebel; J Cervos-Navarro
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; K Sakaguchi; E Appella; J R Yannelli; G J Adema; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 8.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

9.  Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma.

Authors:  Qing-Qing Xu; Qing-Jie Li; Cheng-Long Huang; Mu-Yan Cai; Mei-Fang Zhang; Shao-Han Yin; Li-Xia Lu; Lei Chen
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

10.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.